Gene: SLC11A2
Official Full Name: solute carrier family 11 member 2provided by HGNC
Gene Summary: This gene encodes a member of the solute carrier family 11 protein family. The product of this gene transports divalent metals and is involved in iron absorption. Mutations in this gene are associated with hypochromic microcytic anemia with iron overload. A related solute carrier family 11 protein gene is located on chromosome 2. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Apr 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14093 | SLC11A2 Knockout cell line (HeLa) | Human | SLC11A2 | 1:3~1:6 | Negative | Online Inquiry |
KO14094 | SLC11A2 Knockout cell line (HCT 116) | Human | SLC11A2 | 1:2~1:4 | Negative | Online Inquiry |
KO14095 | SLC11A2 Knockout cell line (HEK293) | Human | SLC11A2 | 1:3~1:6 | Negative | Online Inquiry |
KO14096 | SLC11A2 Knockout cell line (A549) | Human | SLC11A2 | 1:3~1:4 | Negative | Online Inquiry |
SLC11A2 Gene Knockout Cell Lines are specifically engineered cellular models designed to study the functional role of the SLC11A2 gene, which encodes a protein critical for divalent metal ion transport in cells, particularly iron and manganese. By creating knockout variants, these cell lines enable researchers to explore the gene's contributions to various physiological and pathological processes, including iron homeostasis and susceptibility to certain diseases.
The key functional mechanism of the SLC11A2 knockout is the absence of the gene product, which disrupts the normal transport of iron across the cellular membrane, leading to changes in intracellular iron levels and potential downstream effects on cellular metabolism. This makes these cell lines invaluable for investigating iron-related conditions such as anemia, hemochromatosis, and neurodegenerative diseases characterized by metal dysregulation.
Scientifically, SLC11A2 Gene Knockout Cell Lines have applications in both basic research and clinical studies. Researchers can utilize these models to elucidate disease mechanisms, test new therapeutic approaches targeting iron transport, and screen for compounds that may restore normal function or mitigate pathology in iron-related disorders.
One of the primary advantages of using SLC11A2 knockout cell lines over conventional models is their specificity and precision; these lines have been thoroughly validated to ensure fidelity in knockout efficiency, resulting in reproducible experimental outcomes. Furthermore, they offer researchers unique insights that are often unattainable with less targeted approaches such as pharmacological inhibition.
For researchers and clinicians alike, these knockout cell lines represent a powerful tool in the exploration of iron metabolism and related pathologies. The ability to effectively assess gene function can drive innovation in therapeutic development and enhance our understanding of complex biological systems.
At our company, we pride ourselves on delivering high-quality scientific products, supported by cutting-edge research and development practices. Our expertise in genetic engineering and cell line creation ensures that the SLC11A2 Gene Knockout Cell Lines meet the highest standards of reliability and performance, empowering researchers to achieve their scientific goals.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.